Literature DB >> 22718545

Mesenchymal stem cells restore cortical rewiring after neonatal ischemia in mice.

Cindy T J van Velthoven1, Yohan van de Looij, Annemieke Kavelaars, Jitske Zijlstra, Frank van Bel, Petra S Huppi, Stéphane Sizonenko, Cobi J Heijnen.   

Abstract

OBJECTIVE: A study was undertaken to investigate the effect of neonatal hypoxic-ischemic (HI) brain damage and mesenchymal stem cell (MSC) treatment on the structure and contralesional connectivity of motor function-related cerebral areas.
METHODS: Brain remodeling after HI±MSC treatment in neonatal mice was analyzed using diffusion tensor magnetic resonance imaging, immunohistochemistry, anterograde tracing with biotinylated dextran amine (BDA), and retrograde tracing with fluorescent pseudorabies virus (PRV).
RESULTS: MSC treatment after HI reduced contralesional rewiring taking place after HI. Following MSC treatment, fractional anisotropy values, which were increased in both ipsi- and contralesional cortices and decreased in the corpus callosum (CC) after HI, were normalized to the level observed in sham-operated mice. These results were corroborated by myelin basic protein intensity and staining pattern in these areas. Anterograde tracing of ipsilesional motor neurons showed that after MSC treatment, fewer BDA-positive fibers crossed the CC and extended into the contralesional motor cortex compared to HI mice. This remodeling was functional, because retrograde labeling showed increased connectivity between impaired (left) forepaw and the contralesional (left) motor cortex after HI, whereas MSC treatment reduced this connection and increased the connection between the impaired (left) forepaw and the ipsilesional (right) motor cortex. Finally, the extent of contralesional rewiring measured with BDA and PRV tracing was related to sensorimotor dysfunction.
INTERPRETATION: This is the first study to describe MSC treatment after neonatal HI markedly reducing contralesional axonal remodeling induced by HI brain injury.
Copyright © 2012 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718545     DOI: 10.1002/ana.23543

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  30 in total

Review 1.  Brain-peripheral cell crosstalk in white matter damage and repair.

Authors:  Kazuhide Hayakawa; Eng H Lo
Journal:  Biochim Biophys Acta       Date:  2015-08-13

2.  Therapeutic potential of genetically modified mesenchymal stem cells after neonatal hypoxic-ischemic brain damage.

Authors:  Cindy Tj van Velthoven; Luca Braccioli; Hanneke Ldm Willemen; Annemieke Kavelaars; Cobi J Heijnen
Journal:  Mol Ther       Date:  2013-10-31       Impact factor: 11.454

Review 3.  Cell based therapies for ischemic stroke: from basic science to bedside.

Authors:  Xinfeng Liu; Ruidong Ye; Tao Yan; Shan Ping Yu; Ling Wei; Gelin Xu; Xinying Fan; Yongjun Jiang; R Anne Stetler; George Liu; Jieli Chen
Journal:  Prog Neurobiol       Date:  2013-12-12       Impact factor: 11.685

4.  Murine model: maternal administration of stem cells for prevention of prematurity.

Authors:  Jun Lei; Wance Firdaus; Jason M Rosenzweig; Shorouq Alrebh; Ahmed Bakhshwin; Talaibek Borbiev; Ali Fatemi; Karin Blakemore; Michael V Johnston; Irina Burd
Journal:  Am J Obstet Gynecol       Date:  2014-12-30       Impact factor: 8.661

Review 5.  Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.

Authors:  Li-Jin Chew; Cynthia A DeBoy
Journal:  Neuropharmacology       Date:  2015-06-24       Impact factor: 5.250

Review 6.  Stem cell-based therapies for the newborn lung and brain: Possibilities and challenges.

Authors:  S Alex Mitsialis; Stella Kourembanas
Journal:  Semin Perinatol       Date:  2016-01-15       Impact factor: 3.300

Review 7.  The endogenous regenerative capacity of the damaged newborn brain: boosting neurogenesis with mesenchymal stem cell treatment.

Authors:  Vanessa Donega; Cindy T J van Velthoven; Cora H Nijboer; Annemieke Kavelaars; Cobi J Heijnen
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-13       Impact factor: 6.200

Review 8.  Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell.

Authors:  Deepaneeta Sarmah; Harpreet Kaur; Jackson Saraf; Kanta Pravalika; Avirag Goswami; Kiran Kalia; Anupom Borah; Xin Wang; Kunjan R Dave; Dileep R Yavagal; Pallab Bhattacharya
Journal:  Transl Stroke Res       Date:  2017-10-26       Impact factor: 6.829

Review 9.  New innovations: therapeutic opportunities for intellectual disabilities.

Authors:  Jonathan D Picker; Christopher A Walsh
Journal:  Ann Neurol       Date:  2013-09       Impact factor: 10.422

Review 10.  Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system.

Authors:  Alice Laroni; Giovanni Novi; Nicole Kerlero de Rosbo; Antonio Uccelli
Journal:  J Neuroimmune Pharmacol       Date:  2013-04-12       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.